|
1
|
Kedersha NL and Rome LH: Isolation and
characterization of a novel ribonucleoprotein particle: Large
structures contain a single species of small RNA. J Cell Biol.
103:699–709. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stadler PF, Chen JJ, Hackermüller J,
Hoffmann S, Horn F, Khaitovich P, Kretzschmar AK, Mosig A, Prohaska
SJ, Qi X, et al: Evolution of vault RNAs. Mol Biol Evol.
26:1975–1991. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kickhoefer VA, Searles RP, Kedersha NL,
Garber ME, Johnson DL and Rome LH: Vault ribonucleoprotein
particles from rat and bullfrog contain a related small RNA that is
transcribed by RNA polymerase III. J Biol Chem. 268:7868–7873.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee K, Kunkeaw N, Jeon SH, Lee I, Johnson
BH, Kang GY, Bang JY, Park HS, Leelayuwat C and Lee YS: Precursor
miR-886, a novel noncoding RNA repressed in cancer, associates with
PKR and modulates its activity. RNA. 17:1076–1089. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nandy C, Mrázek J, Stoiber H, Grässer FA,
Hüttenhofer A and Polacek N: Epstein-Barr virus-induced expression
of a novel human vault RNA. J Mol Biol. 388:776–784. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li F, Chen Y, Zhang Z, Ouyang J, Wang Y,
Yan R, Huang S, Gao GF, Guo G and Chen JL: Robust expression of
vault RNAs induced by influenza A virus plays a critical role in
suppression of PKR-mediated innate immunity. Nucleic Acids Res.
43:10321–10337. 2015.PubMed/NCBI
|
|
8
|
Amort M, Nachbauer B, Tuzlak S, Kieser A,
Schepers A, Villunger A and Polacek N: Expression of the vault RNA
protects cells from undergoing apoptosis. Nat Commun. 6:70302015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gopinath SC, Wadhwa R and Kumar PK:
Expression of noncoding vault RNA in human malignant cells and its
importance in mitoxantrone resistance. Mol Cancer Res. 8:1536–1546.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen J, OuYang H, An X and Liu S: Vault
RNAs partially induces drug resistance of human tumor cells MCF-7
by binding to the RNA/DNA-binding protein PSF and inducing oncogene
GAGE6. PLoS One. 13:e01913252018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bracher L, Ferro I, Pulido-Quetglas C,
Ruepp MD, Johnson R and Polacek N: Human vtRNA1-1 levels modulate
signaling pathways and regulate apoptosis in human cancer cells.
Biomolecules. 10:6142020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferro I, Gavini J, Gallo S, Bracher L,
Landolfo M, Candinas D, Stroka DM and Polacek N: The human vault
RNA enhances tumorigenesis and chemoresistance through the lysosome
in hepatocellular carcinoma. Autophagy. 18:191–203. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Horos R, Buscher M, Kleinendorst R,
Alleaume AM, Tarafder AK, Schwarzl T, Dziuba D, Tischer C, Zielonka
EM, Adak A, et al: The small non-coding vault RNA1-1 acts as a
riboregulator of autophagy. Cell. 176:1054–1067. e122019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Buscher M, Horos R, Huppertz I, Haubrich
K, Dobrev N, Baudin F, Hennig J and Hentze MW: Vault RNA1-1
riboregulates the autophagic function of p62 by binding to lysine 7
and arginine 21, both of which are critical for p62
oligomerization. RNA. 28:742–755. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gallo S, Kong E, Ferro I and Polacek N:
Small but powerful: The human vault RNAs as multifaceted modulators
of pro-survival characteristics and tumorigenesis. Cancers (Basel).
14:27872022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nolte-'t Hoen EN, Buermans HP, Waasdorp M,
Stoorvogel W, Wauben MH and 't Hoen PA: Deep sequencing of RNA from
immune cell-derived vesicles uncovers the selective incorporation
of small non-coding RNA biotypes with potential regulatory
functions. Nucleic Acids Res. 40:9272–9285. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shurtleff MJ, Yao J, Qin Y, Nottingham RM,
Temoche-Diaz MM, Schekman R and Lambowitz AM: Broad role for YBX1
in defining the small noncoding RNA composition of exosomes. Proc
Natl Acad Sci USA. 114:E8987–E8995. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ramayanti O, Verkuijlen SAWM, Novianti P,
Scheepbouwer C, Misovic B, Koppers-Lalic D, van Weering J, Beckers
L, Adham M, Martorelli D, et al: Vesicle-bound EBV-BART13-3p miRNA
in circulation distinguishes nasopharyngeal from other head and
neck cancer and asymptomatic EBV-infections. Int J Cancer.
144:2555–2566. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakai W, Yoshida T, Diez D, Miyatake Y,
Nishibu T, Imawaka N, Naruse K, Sadamura Y and Hanayama R: A novel
affinity-based method for the isolation of highly purified
extracellular vesicles. Sci Rep. 6:339352016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Motokura T, Kobayashi Y, Fujita A,
Nakamura Y, Taniguchi T, Uchimaru K and Asano S: Clinical
significance of serial measurement of the serum levels of soluble
interleukin-2 receptor and soluble CD8 in malignant lymphoma. Leuk
Lymphoma. 16:355–362. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jeppesen DK, Fenix AM, Franklin JL,
Higginbotham JN, Zhang Q, Zimmerman LJ, Liebler DC, Ping J, Liu Q,
Evans R, et al: Reassessment of exosome composition. Cell.
177:428–445. e182019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schneider RJ, Seibert K, Passe S, Little
C, Gee T, Lee BJ III, Miké V and Young CW: Prognostic significance
of serum lactate dehydrogenase in malignant lymphoma. Cancer.
46:149–143. 1980. View Article : Google Scholar
|
|
24
|
Geva M, Pryce A, Shouval R, Fein JA,
Danylesko I, Shem-Tov N, Yerushalmi R, Shimoni A, Szydlo R, Pavlu J
and Nagler A: High lactate dehydrogenase at time of admission for
allogeneic hematopoietic transplantation associates to poor
survival in acute myeloid leukemia and non-Hodgkin lymphoma. Bone
Marrow Transplamt. 56:2690–2696. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tilly H, Castaigne S, Bordessoule D,
Casassus P, Le Prisé PY, Tertian G, Desablens B, Henry-Amar M and
Degos L: Low-dose cytarabine versus intensive chemotherapy in the
treatment of acute nonlymphocytic leukemia in the elderly. J Clin
Oncol. 8:272–279. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carella AM, Podesta M, Frassoni F, Raffo
MR, Pollicardo N, Pungolino E, Vimercati R, Sessarego M, Parodi C,
Rabitti C, et al: Collection of ‘normal’ blood repopulating cells
during early hemopoietic recovery after intensive conventional
chemotherapy in chronic myelogenous leukemia. Bone Marrow
Transplant. 12:267–271. 1993.PubMed/NCBI
|
|
27
|
Du Bois D and Du Bois EF: A formula to
estimate the approximate surface area if height and weight be
known. Arch Intern Med. 17:863–871. 1916. View Article : Google Scholar
|
